Business Wire

• Presentation will describe how clofutriben modulates key biomarkers of prednisolone efficacy and toxicity in patients with polymyalgia rheumatica.
• Sparrow’s Chief Scientific Officer will describe new insights about glucocorticoid action on the 75th anniversary of glucocorticoid utilization for treatment of rheumatic diseases.

PORTLAND, Ore.--(BUSINESS WIRE)-- Sparrow Pharmaceuticals will present interim results from a Phase 2 clinical trial of its novel... (continue reading...)

BELLEVUE, Wash.--(BUSINESS WIRE)-- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company’s Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to $5 million maximum amount, for the repurchase of the Company's outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions. The... (continue reading...)

SAN FRANCISCO--(BUSINESS WIRE)-- Today, Eventbrite is releasing Niche to Meet You™, a new report offering insights into today’s dating scene, focusing on the transition from online to offline dating and highlighting the activities preferred by Gen Z and Millennials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240606525971/en/

Eventbrite Niche to Meet You logo (Graphic: Eventbrite)

In the past year,... (continue reading...)

ATLab Indianapolis represents significant initial step in the company’s strategy to address challenges of the radiopharmaceutical sector in terms of production and supply of radioligand therapies.

BROWNSBURG, Ind. & PARIS--(BUSINESS WIRE)-- Regulatory News:

Orano Med (a subsidiary of the Orano Group), a pioneer in the development of targeted alpha therapies for oncology, today inaugurated its first ATLab (Alpha Therapy Laboratory), located in Brownsburg near... (continue reading...)

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Equilar, a leader in executive intelligence solutions, is pleased to announce the expansion of its strategic partnership with Equity Methods, a premier provider of equity compensation solutions. This enhanced collaboration builds on the partnership established in 2022 when Equilar and Equity Methods introduced the Monte Carlo Simulator for relative TSR-based award valuations.

Equilar and Equity Methods launched the Monte... (continue reading...)